Vogt-Koyanagi-Harada Disease Associated with COVID-19 mRNA Vaccine
- PMID: 34505819
- DOI: 10.1080/09273948.2021.1974492
Vogt-Koyanagi-Harada Disease Associated with COVID-19 mRNA Vaccine
Abstract
A 54-year-old Chinese male with no previous ocular history presented to the ophthalmology department for the bilateral acute painless blurring of vision after receiving the 1st dose of COVID-19 mRNA vaccine (PFIZER-BioNTech/COMIRNATY). Clinical examination and imaging tests were consistent with Vogt-Koyanagi-Hara disease. The patient responded well with a high dose of intravenous methylprednisolone followed by a tapering dose of oral prednisolone.
Keywords: COVID-19 vaccine; PfizerBioNtech; VKH disease; exudative retinal detachment; vaccine side effects.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical